Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 1
2008 2
2009 1
2010 2
2011 4
2012 2
2013 1
2014 2
2015 3
2016 8
2017 8
2018 5
2019 3
2020 3
2021 5
2022 2
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
TP53 in bone and soft tissue sarcomas.
Thoenen E, Curl A, Iwakuma T. Thoenen E, et al. Among authors: iwakuma t. Pharmacol Ther. 2019 Oct;202:149-164. doi: 10.1016/j.pharmthera.2019.06.010. Epub 2019 Jul 2. Pharmacol Ther. 2019. PMID: 31276706 Free PMC article. Review.
Mutant p53 suppresses innate immune signaling to promote tumorigenesis.
Ghosh M, Saha S, Bettke J, Nagar R, Parrales A, Iwakuma T, van der Velden AWM, Martinez LA. Ghosh M, et al. Among authors: iwakuma t. Cancer Cell. 2021 Apr 12;39(4):494-508.e5. doi: 10.1016/j.ccell.2021.01.003. Epub 2021 Feb 4. Cancer Cell. 2021. PMID: 33545063 Free PMC article.
MDM2, an introduction.
Iwakuma T, Lozano G. Iwakuma T, et al. Mol Cancer Res. 2003 Dec;1(14):993-1000. Mol Cancer Res. 2003. PMID: 14707282 Review.
The interplay between mutant p53 and the mevalonate pathway.
Parrales A, Thoenen E, Iwakuma T. Parrales A, et al. Among authors: iwakuma t. Cell Death Differ. 2018 Mar;25(3):460-470. doi: 10.1038/s41418-017-0026-y. Epub 2017 Dec 13. Cell Death Differ. 2018. PMID: 29238070 Free PMC article. Review.
Regulators of Oncogenic Mutant TP53 Gain of Function.
Yamamoto S, Iwakuma T. Yamamoto S, et al. Among authors: iwakuma t. Cancers (Basel). 2018 Dec 20;11(1):4. doi: 10.3390/cancers11010004. Cancers (Basel). 2018. PMID: 30577483 Free PMC article. Review.
Non-Canonical Cell Death Induced by p53.
Ranjan A, Iwakuma T. Ranjan A, et al. Among authors: iwakuma t. Int J Mol Sci. 2016 Dec 9;17(12):2068. doi: 10.3390/ijms17122068. Int J Mol Sci. 2016. PMID: 27941671 Free PMC article. Review.
p53 as a Regulator of Lipid Metabolism in Cancer.
Parrales A, Iwakuma T. Parrales A, et al. Among authors: iwakuma t. Int J Mol Sci. 2016 Dec 10;17(12):2074. doi: 10.3390/ijms17122074. Int J Mol Sci. 2016. PMID: 27973397 Free PMC article. Review.
Targeting Oncogenic Mutant p53 for Cancer Therapy.
Parrales A, Iwakuma T. Parrales A, et al. Among authors: iwakuma t. Front Oncol. 2015 Dec 21;5:288. doi: 10.3389/fonc.2015.00288. eCollection 2015. Front Oncol. 2015. PMID: 26732534 Free PMC article. Review.
61 results